Development of pH-Responsive, Thermosensitive, Antibacterial, and Anticancer CS/PVA/Graphene Blended Hydrogels for Controlled Drug Delivery

• Published in: Gels Vol. 10; no. 3; p. 205
• Main Authors: Mansha, Saira, Sajjad, Amna, Zarbab, Aneeqa, Afzal, Tahmina, Kanwal, Zakia, Iqbal, Muhammad Javaid, Raza, Mohsin Ali, Ali, Sharafat
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-03-2024; MDPI
• Subjects: Antibacterial agents; Atomic force microscopy; Biocompatibility; biodegradable; Cancer therapies; Chitosan; Contact angle; Controlled release; Drug delivery systems; Drug therapy; Drugs; Farmakologi; Fourier transforms; GNS-based hydrogel; Graphene; Health aspects; hemocompatible; hepatocellular carcinoma; Hydrogels; Hydrogen-ion concentration; Infrared spectroscopy; Kinetics; Liver cancer; Medical research; Medicine, Experimental; Methotrexate; Pharmacology; Polymers; Polyvinyl alcohol; Side effects; Tissue engineering; Toxicity; Vehicles; Pakistan; methotrexate; biodegradable; hemocompatible; GNS-based hydrogel; hepatocellular carcinoma
• ISSN: 2310-2861; 2310-2861
• DOI: 10.3390/gels10030205

Drug delivery techniques based on polymers have been investigated for their potential to improve drug solubility, reduce systemic side effects, and controlled and targeted administration at infection site. In this study, we developed a co-polymeric hydrogel composed of graphene sheets (GNS), polyvinyl alcohol (PVA), and chitosan (CS) that is loaded with methotrexate (MTX) for in vitro liver cancer treatment. Fourier transform infrared spectroscopy (FTIR) and atomic force microscopy (AFM) was employed to check the structural properties and surface morphology. Moreover, tests were conducted on the cytotoxicity, hemolytic activity, release kinetics, swelling behaviour and degradation of hydrogels. A controlled release of drug from hydrogel in PBS at pH 7.4 was examined using release kinetics. Maximal drug release in six hours was 97.34%. The prepared hydrogels did not encourage the HepG2 growth and were non-hemolytic. The current study highlights the potential of GNS-based hydrogel loaded with MTX as an encouraging therapy for hepatocellular carcinoma. HepG2 cell viability of MTX-loaded CS-PVA-GNS hydrogel was (IC50 5.87 µg/200 mL) in comparison to free MTX (IC50 5.03 µg/200 mL). These outcomes recommend that hydrogels with GNS ensure improved drug delivery in cancer microenvironment while lessening adverse consequences on healthy cells.